Canterbury DHB

Context

AIDS-related Lymphoma (ARL)

The prognosis of ARL has improved with developments of infusional regimens, the use of rituximab and transplantation in relapsed disease. Important differences remain in this group of patients. Special attention to prophylaxis of infection is required. See Dunleavy, K.et al. (2012). "How I treat HIV-associated lymphoma." Blood 119: 3245-55.

About this Canterbury DHB document (9649):

Document Owner:

Peter Ganly (see Who's Who)

Issue Date:

November 2018

Next Review:

November 2021

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 9649